Using Psychedelics and Ketamine to Treat Nociplastic Pain

Explore the potential of psychedelics and ketamine in treating nociplastic pain through this informative 31-minute webinar presented by Dr. Michelle Weiner, a double board-certified expert in Interventional Pain Medicine and Physical Medicine and Rehabilitation. Delve into the current opioid epidemic and mental health crisis while learning about the emerging psychedelic renaissance. Gain insights into nociplastic pain, a newer phenomenon involving neural circuitry changes in chronic pain perception. Discover how the Biopsychosocial Model of Pain can address root causes by altering sensory processing in the nervous system. Examine the personalized use of ketamine as a dissociative anesthetic and its potential role in reducing central sensitization. Understand how psychedelics may quiet the Default Mode Network, activate 5HT2A receptors, and catalyze changes in perception and behavior. Learn about the importance of integrating experiences for lasting effects. Earn PACE credits by watching the webinar and following the provided instructions.